Culture & Sensitivity, Aerobic bacteria Pus (Manual method)
Bacterial/ Viral0 parametersReport in 72HrsAt Home
No Fasting Required
Details
It identifies the causative bacteria and determines the antibiotics to which the bacteria are sensitive, resistant, or intermediate
₹199₹1,600
88% OFF
FREE:AI Insights
Culture & Sensitivity Aerobic bacteria Pus (Manual method)
- Why is it done?
- Identifies aerobic bacterial pathogens causing localized infections in purulent material (pus) to guide targeted antibiotic therapy
- Determines antibiotic susceptibility patterns to ensure appropriate antimicrobial selection and prevent resistance development
- Performed when patients present with signs of bacterial infection including abscess, wound infection, or localized suppurative conditions
- Indicated for post-operative infections, traumatic wounds, surgical site complications, or clinically suspected bacterial infections with pus formation
- Typically ordered when empiric antibiotic therapy is ineffective or when clinical judgment requires organism identification and resistance patterns
- Essential in immunocompromised patients, diabetic patients, or cases where treatment failure occurs
- Normal Range
- Normal Result: No growth of aerobic bacteria after 24-48 hours of incubation on standard culture media (blood agar, chocolate agar, MacConkey agar)
- Interpretation: Absence of pathogenic aerobic bacteria indicates either no active aerobic bacterial infection or effective antimicrobial therapy; however, anaerobic bacteria may still be present requiring separate testing
- Colony Count Interpretation:
- ≥10⁵ CFU/mL (Colony Forming Units per milliliter): Significant bacteriuria or infection
- 10³-10⁴ CFU/mL: Borderline; may indicate contamination or early infection requiring clinical correlation
- <10³ CFU/mL: Generally considered contamination or non-significant colonization
- For pus specimens, quantification may vary; presence of any pathogenic organism in pure or predominant culture is clinically significant
- Interpretation
- Positive Culture Result (Significant Growth): Confirms bacterial infection; identifies the specific causative organism(s) allowing targeted antibiotic therapy rather than empiric treatment
- Common Aerobic Pathogens in Pus:
- Staphylococcus aureus: Most common cause of skin/soft tissue infections; increasingly includes MRSA (methicillin-resistant strains)
- Streptococcus species: Including Group A Streptococcus (GAS); associated with cellulitis and wound infections
- Escherichia coli (E. coli): Gram-negative rod; particularly in abdominal or perineal infections
- Pseudomonas aeruginosa: Associated with hospital-acquired infections and wounds in moist environments
- Proteus species and other Enterobacteriaceae: Associated with urinary tract-related infections and abdominal sources
- Sensitivity Reporting: Antibiotic susceptibility reported as Susceptible (S), Intermediate (I), or Resistant (R) based on zone diameter measurements or MIC (Minimum Inhibitory Concentration) values
- Susceptible (S): Organism will likely respond to antimicrobial therapy at recommended doses
- Intermediate (I): Organism may respond to therapy with higher doses or at specific sites; clinical judgment required
- Resistant (R): Organism unlikely to respond to standard antimicrobial therapy; alternative treatment required
- Mixed Flora: Multiple organisms may indicate contamination or polymicrobial infection; clinical correlation essential to distinguish pathogenic organisms from contaminants
- No Growth: May indicate technical issues, inadequate specimen quality, prior antibiotic therapy, or absence of aerobic infection (anaerobic pathogens may still be present)
- Factors Affecting Results: Recent antibiotic use may reduce culture positivity; contamination during collection or transport affects interpretation; improper specimen handling may lead to organism overgrowth or death
- Associated Organs
- Primary Systems Involved:
- Integumentary System: Skin and soft tissue infections including abscesses, boils, folliculitis, cellulitis, and impetigo
- Musculoskeletal System: Osteomyelitis (bone infection) and septic arthritis (joint infections) with abscess formation
- Gastrointestinal System: Perirectal abscesses, appendicitis with suppuration, intra-abdominal abscesses, and peritonitis
- Respiratory System: Lung abscesses, empyema (pus in pleural space), and bronchoalveolar infections
- Reproductive System: Bartholin's gland abscess, prostatic abscess, and tubo-ovarian abscess
- Neurological System: Brain abscess and spinal cord abscess (meningitis-related)
- Associated Diseases and Conditions:
- Surgical Site Infections (SSI): Post-operative wound complications requiring identification of causative organisms
- Diabetic Foot Ulcers: Complex polymicrobial infections; culture guides targeted antibiotic selection
- Sepsis and Bacteremia: Abscess culture critical for identifying source and tailoring antimicrobial therapy
- Immunocompromised Conditions: HIV/AIDS, neutropenia, immunosuppressive therapy; culture identifies opportunistic and unusual aerobic pathogens
- Potential Complications from Abnormal Results:
- Inadequately treated infections may lead to sepsis, systemic inflammatory response syndrome (SIRS), and multi-organ failure
- Delayed appropriate therapy increases morbidity and mortality, particularly with virulent organisms like MRSA or Pseudomonas
- Antibiotic resistance development with inappropriate or prolonged antibiotic use without targeted therapy
- Chronic osteomyelitis or recurrent infections if source infection inadequately treated
- Follow-up Tests
- Repeat Culture and Sensitivity: Performed 48-72 hours post-initiation of targeted therapy to verify organism eradication and appropriate antibiotic efficacy in non-responding cases
- Anaerobic Culture: Recommended if anaerobic pathogens suspected (source from anaerobic sites, foul-smelling discharge, or initial culture negative despite clinical infection)
- Fungal Culture: Consider if patient immunocompromised, fungal elements visible on Gram stain, or no growth on aerobic/anaerobic cultures despite clinical suspicion
- Mycobacterial Culture: Indicated for chronic infections, immunocompromised patients, or granulomatous lesions
- Gram Stain Microscopy: Provides preliminary organism morphology and can guide empiric therapy while culture results pending (48-72 hours)
- Blood Culture: Ordered simultaneously in cases of suspected bacteremia or sepsis to identify if same organism is causing systemic infection
- Complete Blood Count (CBC): Monitors treatment response; rising WBC count may indicate inadequate therapy or new infection
- Inflammatory Markers (CRP, ESR): C-reactive protein and erythrocyte sedimentation rate track infection resolution; should decline with appropriate therapy
- Procalcitonin: More specific marker for bacterial infection; useful for monitoring therapy response in severe infections or sepsis
- Imaging Studies (Ultrasound, CT, MRI): To assess extent of infection, locate additional abscesses, or guide drainage procedures; ordered based on clinical presentation
- Serum Creatinine and Liver Function Tests: Essential in severe infections; monitors for organ dysfunction and guides antibiotic dosing adjustments
- Lactic Acid: Elevated in sepsis; useful prognostic marker and indicator of tissue hypoperfusion
- Extended Spectrum Beta-Lactamase (ESBL) Testing: Performed if resistant Gram-negative organisms isolated to identify production of resistance genes
- MRSA-specific Susceptibility Testing: For Staphylococcus aureus isolates; determines oxacillin/methicillin resistance and guides selection of agents like vancomycin or linezolid
- PCR-based Molecular Testing: For rapid pathogen identification and resistance gene detection in select cases where immediate results critical for clinical management
- Fasting Required?
- Fasting Required: No
- Specimen Type: Pus (purulent material) collected directly from wound, abscess, or infection site; not a blood-based test, therefore fasting irrelevant
- Special Specimen Collection Instructions:
- Collect minimum 2-3 mL of pus in sterile container without preservatives or saline (for optimal aerobic culture)
- Use sterile swabs for collection; minimum 2 swabs recommended for both culture and Gram stain preparation
- Cleanse collection site with antiseptic solution (70% alcohol or iodine-based solution); remove excess antiseptic to prevent culture inhibition
- Avoid contamination from surrounding skin flora; use aspiration technique when possible rather than swab collection
- Transport specimen immediately to laboratory in sterile container; do not refrigerate if aerobic culture desired (cold temperatures may inhibit growth)
- Maintain specimen at room temperature (20-25°C) during transport; prolonged delays reduce organism recovery
- For wounds with drainage: collect pus from deepest part of wound using aseptic technique; express drainage without squeezing surrounding tissue
- Medications and Preparation:
- Continue prescribed antibiotics unless specifically instructed otherwise by physician; delay in obtaining culture should not delay antibiotic initiation in suspected bacterial infection
- Obtain culture before starting antibiotics if possible to improve organism recovery rate
- Avoid topical antiseptics or antibiotic ointments on collection site 24 hours prior to specimen collection if possible
- Document patient demographics, specimen source/site, collection time, and clinical indication on requisition form for proper interpretation and quality assurance
How our test process works!
